(Q40105438)

English

Nonhomologous end joining is essential for cellular resistance to the novel antitumor agent, beta-lapachone

scientific article

Statements

Nonhomologous end joining is essential for cellular resistance to the novel antitumor agent, beta-lapachone (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit